trending Market Intelligence /marketintelligence/en/news-insights/trending/epdpcfjudtlekpwby_sirg2 content
BY CONTINUING TO USE THIS SITE, YOU ARE AGREEING TO OUR USE OF COOKIES. REVIEW OUR
PRIVACY & COOKIE NOTICE
Log in to other products

Login to Market Intelligence Platform

 /


Looking for more?

Contact Us

Request a Demo

You're one step closer to unlocking our suite of comprehensive and robust tools.

Fill out the form so we can connect you to the right person.

  • First Name*
  • Last Name*
  • Business Email *
  • Phone *
  • Company Name *
  • City *

* Required

In this list

Kubota Pharmaceutical to form ophthalmology joint venture with SBI Holdings

L.K. Bennett: Bankruptcy Case Study

State Of Singapore Online Video Subscription

Power Forecast Briefing: Capacity Shortfalls to Test the Renewable Energy Transition

Episode 43 - More Change, M&A On Horizon For Equity Research Industry


Kubota Pharmaceutical to form ophthalmology joint venture with SBI Holdings

Kubota Pharmaceutical Holdings Co. Ltd. plans to form a joint venture with SBI Holdings Inc. to invest in ophthalmic drugs and devices.

The entity will be 51% funded by Kubota Pharma and 49% by SBI Holdings and is likely to first invest in mobile healthcare applications in the field of ophthalmology.

Kubota Pharmaceutical is the parent of Acucela Inc.